Enliven Therapeutics, Inc. ELVN
51.20 USD -0.35 (-0.68%)
At closeNov 11, 2026, 4:00 AM EST
51.00 -0.20 -0.39%
Pre-market · Nov 11, 4:00 AM ET
49.74 Day range 51.81
14.79 52-week range 62.32
- YTD
- +232.47%
- 1 year
- +173.65%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 119.66M | 104.55M | 83.53M | 38.79M | 51.44M | |
| 85.86M | 80.78M | 64.57M | 31.02M | 38.44M | |
| 33.80M | 23.78M | 18.95M | 7.77M | 13.00M | |
| -119.66M | -104.55M | -83.53M | -38.79M | -51.44M | |
| -103.69M | -89.02M | -71.58M | -37.66M | -51.38M | |
| -103.69M | -89.02M | -71.58M | -37.66M | -51.38M | |
| -103.69M | -89.02M | -71.58M | -37.66M | -51.38M | |
| -103.69M | -89.02M | -71.58M | -37.66M | -51.38M | |
| -1.83 | -1.89 | -2.01 | -12.05 | -9.50 | |
| -1.83 | -1.89 | -2.01 | -12.05 | -9.50 | |
| -1.83 | -1.89 | -2.01 | -12.05 | -9.50 | |
| -103.69M | -88.79M | -71.58M | -37.66M | -51.38M | |
| -103.69M | -88.79M | -71.58M | -37.66M | -51.38M | |
| 56.66M | 47.07M | 35.55M | 3.12M | 5.42M | |
| 56.66M | 47.07M | 35.55M | 3.12M | 5.42M |